A multicentre, Phase II, open-label, randomized study in previously untreated patients with advanced indolent non-hodgkin's lymphoma evaluating the benefit of GA101 (RO5072759) plus chemotherapy compared with Rituximab plus chemotherapy followed by GA101 or Rituximab maintenance therapy in responders BO21223

Project: Research

Project Details

Effective start/end date17/07/1916/07/24


  • clinical trial
  • phase 2 study
  • treatment efficacy
  • lymphoma